2-PROPYNYL ADENOSINE ANALOGS WITH MODIFIED 5'-RIBOSE GROUPS HAVING A2A AGONIST ACTIVITY
The invention provides compounds having the following general formula (I): wherein X, R1, R2, R7 and Z are as described herein.
Saved in:
Main Authors | , , , , , |
---|---|
Format | Patent |
Language | English French |
Published |
30.09.2014
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The invention provides compounds having the following general formula (I): wherein X, R1, R2, R7 and Z are as described herein. |
---|---|
AbstractList | The invention provides compounds having the following general formula (I): wherein X, R1, R2, R7 and Z are as described herein. |
Author | MURPHREE, LAUREN J FIGLER, ROBERT ALAN MACDONALD, TIMOTHY L LINDEN, JOEL M SULLIVAN, GAIL W RIEGER, JAYSON M |
Author_xml | – fullname: LINDEN, JOEL M – fullname: FIGLER, ROBERT ALAN – fullname: MURPHREE, LAUREN J – fullname: MACDONALD, TIMOTHY L – fullname: RIEGER, JAYSON M – fullname: SULLIVAN, GAIL W |
BookMark | eNqFyr0OgjAQAOAOOvj3DN7mxFIDup6llEuw19AKYSLE1MkACb5_XNydvuXbitU4jXEjWpm4ml1nuwow15Y9WQ1osWLjoaVQwp1zKkjnkJ6Smm7sNZiaH85DiQ1ZAygR0LAlHwBVoIZCtxfr1_Be4uHnThwLHVSZxHnq4zIPzzjGT69QppfsKjN1_j--DdAxjg |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
DocumentTitleAlternate | ANALOGUES DE 2-PROPYNYLE ADENOSINE COMPRENANT DES GROUPES 5'-RIBOSE MODIFIES PRESENTANT UNE ACTIVITE AGONISTE A2A |
ExternalDocumentID | CA2576826C |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_CA2576826C3 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 15:57:05 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English French |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_CA2576826C3 |
Notes | Application Number: CA20052576826 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20140930&DB=EPODOC&CC=CA&NR=2576826C |
ParticipantIDs | epo_espacenet_CA2576826C |
PublicationCentury | 2000 |
PublicationDate | 20140930 |
PublicationDateYYYYMMDD | 2014-09-30 |
PublicationDate_xml | – month: 09 year: 2014 text: 20140930 day: 30 |
PublicationDecade | 2010 |
PublicationYear | 2014 |
RelatedCompanies | ADENOSINE THERAPEUTICS LLC UNIVERSITY OF VIRGINIA PATENT FOUNDATION |
RelatedCompanies_xml | – name: ADENOSINE THERAPEUTICS LLC – name: UNIVERSITY OF VIRGINIA PATENT FOUNDATION |
Score | 2.9498332 |
Snippet | The invention provides compounds having the following general formula (I): wherein X, R1, R2, R7 and Z are as described herein. |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | CHEMISTRY DERIVATIVES THEREOF HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY NUCLEIC ACIDS NUCLEOSIDES NUCLEOTIDES ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SUGARS |
Title | 2-PROPYNYL ADENOSINE ANALOGS WITH MODIFIED 5'-RIBOSE GROUPS HAVING A2A AGONIST ACTIVITY |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20140930&DB=EPODOC&locale=&CC=CA&NR=2576826C |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3fT8IwEL4gGvVNUYO_-2Dm0yKOMeBhMaXbWA2sC5sgT2RsEH0ZRGb8971WUF94a9rk0l7y9e7a7-4A7ow52qQ2Ii3LWhigJAgp9JvrupkapjR45qMqX9wPLP_FfH5tvJbgbZMLo-qEfqniiIioFPFeqPt6-feI5Shu5eph-o5Tiycvth1tHR3L6k31muZ0bDcUjmAaYzajWjCwlV9tWGwHdtGJbkrylzvsyJyU5X-D4h3BXoiy8uIYSrO8Agds03etAvv99Xc3DtfIW53AyNDDgQjHwbhHUHmBkO0yCA1oT3QjMuKxT_rC4R53HdK41we8IyKXKFJ9RHw65EGXUIMS2hUBj2IiySNDHo9P4dZzY-bruMPJrzImjG6OUj-Dcr7IZ1UgVpZmViubN2tZKnkuidlMjEaSmu1aij5O-xyq26RcbF-6hEOp0h92xBWUi4_P2TWa4GJ6o7T3DepQgms |
link.rule.ids | 230,309,783,888,25578,76884 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3PT8IwFH5BNOJNUYM_6cHM0yKOMeCwmNFtrLq1C5v8OJGxQfQyiMz479tWUC_cmjZp2pd8fe-1X78HcKctuE_qcqRlWYcnKAmHFI-bm6qearpwePqjlC8OqOG96s_j1rgEb9u_MFIn9EuKI3JEpRzvhTyvV3-XWLbkVq4fZu-8a_nkxqatbLJjod7UbCh2z3RCZjOsYGxiS6EDU8bVmoH3YJ83OkJl3xn2xJ-U1X-H4h7DQcjnyosTKM3zKlTwtu5aFQ6DzXM3b26Qtz6FkaaGAxZO6MRH3HiUiXIZyKKWz_oRGpHYQwGziUscG7Xu1QHpschBklQfIc8aEtpHlmYhq88oiWIkyCNDEk_OoO46MfZUvsLprzGm2NpupXkO5XyZz2uAjCzNjE62aDeyVPBcEr2daK0k1buNlMc43Quo7ZrlcvdQHSpeHPhTn9CXKzgS5v1hSlxDufj4nN9wd1zMbqUlvwEwY4Vb |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=2-PROPYNYL+ADENOSINE+ANALOGS+WITH+MODIFIED+5%27-RIBOSE+GROUPS+HAVING+A2A+AGONIST+ACTIVITY&rft.inventor=LINDEN%2C+JOEL+M&rft.inventor=FIGLER%2C+ROBERT+ALAN&rft.inventor=MURPHREE%2C+LAUREN+J&rft.inventor=MACDONALD%2C+TIMOTHY+L&rft.inventor=RIEGER%2C+JAYSON+M&rft.inventor=SULLIVAN%2C+GAIL+W&rft.date=2014-09-30&rft.externalDBID=C&rft.externalDocID=CA2576826C |